
Please try another search
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; and MDNA132, an IL-13 Superkine for solid tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, cytokines, or other Superkines. The company is headquartered in Toronto, Canada.
Name | Age | Since | Title |
---|---|---|---|
John H. Sampson | - | 2021 | Independent Director |
Chandrakant J. Panchal | 72 | 2016 | Independent Director |
Albert George Beraldo | 69 | 2016 | Lead Independent Director |
Rosemina Merchant | 65 | 2011 | Founder, Chief Development Officer & Director |
Karen T. Dawes | 70 | 2019 | Independent Director |
John Geltosky | 76 | 2020 | Independent Director |
Burkhard Becher | - | 2022 | Member of Scientific Advisory Board |
David J. Mooney | - | 2022 | Member of Scientific Advisory Board |
Hussein A. Tawbi | - | 2022 | Member of Clinical Advisory Board |
Paolo A. Ascierto | - | 2022 | Member of Clinical Advisory Board |
Lillian L. Siu | - | 2022 | Member of Clinical Advisory Board |
Sergio A. Quezada | 46 | 2022 | Chairman of Scientific Advisory Board |
William L. Redmond | - | 2022 | Member of Scientific Advisory Board |
Fahar Merchant | 65 | 2011 | Founder, Chairman, President & CEO |
Kapil Dhingra | 63 | 2022 | Strategic Advisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review